Walmart halts H-1B visa offers amid Trump’s $100,000 fee increase - Bloomberg
Indivior PLC stock reached a significant milestone, hitting a 52-week high at $25.03. According to InvestingPro data, the company maintains a "GREAT" overall financial health score, with analysts setting price targets between $27 and $34. This marks a notable achievement for the company, reflecting investor confidence and positive market sentiment. Over the past year, Indivior PLC has experienced a remarkable 149.1% increase in its stock price, supported by strong fundamentals including an impressive 84% gross profit margin and management’s aggressive share buyback program. The surge to a 52-week high indicates strong interest from investors, as the company continues to capitalize on its market opportunities and strengthen its position within the industry. For deeper insights into Indivior’s valuation and growth prospects, including 15 additional ProTips, check out the comprehensive Pro Research Report available on InvestingPro.
In other recent news, Indivior PLC reported a substantial earnings beat for the second quarter of 2025, with earnings per share reaching $0.51, significantly surpassing the anticipated $0.24. The company’s revenue also exceeded expectations, totaling $302 million, marking a 24.96% increase over projections. In connection with its financial performance, Indivior has announced restructuring charges between $39 million and $50 million as part of its "Action Agenda" to streamline operations. This initiative aims to simplify the organization by eliminating non-essential activities and increasing operational transparency.
Craig-Hallum has responded to these developments by raising its price target for Indivior from $27 to $34, maintaining a Buy rating on the stock. Meanwhile, Piper Sandler reiterated its Overweight rating with a $27 price target, acknowledging the company’s efficiency initiatives. Indivior has also updated its CFO employment agreements, aligning them with the company’s current forms for U.S.-based executives without altering compensation. These updates are part of Indivior’s broader strategy to focus on the U.S. market and explore strategic options for its Opvee product and ex-U.S. operations.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.